EP Patent

EP2452670A1 — Conveniently implantable sustained release drug compositions

Assigned to Ramscor Inc · Expires 2012-05-16 · 14y expired

What this patent protects

The invention relates to a pharmaceutical formulation for the sustained release of an active agent into the eye, consisting of a biocompatible, biodegradable excipient and an active agent or pharmaceutically acceptable salt thereof; wherein the biocompatible, biodegradable excipi…

USPTO Abstract

The invention relates to a pharmaceutical formulation for the sustained release of an active agent into the eye, consisting of a biocompatible, biodegradable excipient and an active agent or pharmaceutically acceptable salt thereof; wherein the biocompatible, biodegradable excipient is selected from the group consisting of tocopherol isomers and their esters, tocotrienal isomers and their esters, and benzyl benzoate; and wherein the formulation is implanted or injected directly into the eye. The invention also relates to methods and pharmaceutical formulations for specific uses.

Drugs covered by this patent

Patent Metadata

Patent number
EP2452670A1
Jurisdiction
EP
Classification
—
Expires
2012-05-16
Drug substance claim
No
Drug product claim
No
Assignee
Ramscor Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.